15 septiembre 2015
It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting, but a new study could be a game changer for patients, improving both quality of life and longevity.
http://www.sciencedaily.com/releases/2015/09/150915090417.htm
